EVM
AGTC

Eaton Vance Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Eaton Vance Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$2K – 2865
2021
Q4 		$2K Hold
1,000
– – ﹤0.01% 2755
2021
Q3 		$0 Buy
+1,000
New +$3.56K ﹤0.01% 2841

Other funds holding AGTC

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Eaton Vance Management's AGTC Position: Q1 2022 in Review

Eaton Vance Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2022, closing a stake of 1,000 shares — an estimated $2K sold.

Eaton Vance Management first reported a position in AGTC in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q4 2021. 53 funds tracked by Wall St. Rank hold AGTC as of Q1 2022.

  • Eaton Vance Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 1,000 Applied Genetic Technologies Corporation shares in Q1 2022, an estimated $2K.
  • Eaton Vance Management first reported a position in Applied Genetic Technologies Corporation in Q3 2021 and held it in 2 quarters.
  • Eaton Vance Management's Applied Genetic Technologies Corporation position peaked at $2K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.